Abstract
Gastrointestinal infections in neutropenic patients are common especially in the setting of mucotoxic chemotherapy. In this setting common enteric pathogens can easily gain access to the bloodstream and cause bacteremia and severe sepsis. Additionally, other gastrointestinal infections commonly seen in immunocompetent patients such as clostridium difficile colitis can often complicate the clinical picture in neutropenic patients given the broad use of antibiotics.
Genitourinary infections in neutropenic patients occur as a complication of indwelling foley catheters, mucosal inflammation and anatomical abnormalities of the genitourinary tract. Although the pathogenesis is similar to the immunocompetent population, the infections are more frequent and severe in neutropenic patients.
In this chapter, we will discuss the most common type of gastrointestinal and genitourinary tract infections in neutropenic patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Komeno Y, Uryu H, Iwata Y, Hatada Y, Sakamoto J, Iihara K, et al. Esophageal candidiasis as the initial manifestation of acute myeloid leukemia. Int Med (Tokyo, Japan). 2015;54(23):3087–92.
Samonis G, Skordilis P, Maraki S, Datseris G, Toloudis P, Chatzinikolaou I, et al. Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clin Infect Dis. 1998;27(2):283–6.
Darouiche RO. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues. Clin Infect Dis. 1998;26(2):259–72; quiz 73–4.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):409–17.
Kadayakkara DK, Candelaria A, Kwak YE, Loeser C. Herpes simplex virus-2 esophagitis in a young immunocompetent adult. Case Rep Gastrointest Med. 2016;2016:7603484.
Canalejo Castrillero E, Garcia Duran F, Cabello N, Garcia Martinez J. Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine. 2010;89(4):204–10.
Harris J, Smith T, Preis J. Intractable hiccups due to herpetic esophagitis in an immunocompromised patient. IDCases. 2016;4:34–7.
Jazeron JF, Barbe C, Frobert E, Renois F, Talmud D, Brixi-Benmansour H, et al. Virological diagnosis of herpes simplex virus 1 esophagitis by quantitative real-time PCR assay. J Clin Microbiol. 2012;50(3):948–52.
Frobert E, Ooka T, Cortay JC, Lina B, Thouvenot D, Morfin F. Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study. Antimicrob Agents Chemother. 2005;49(3):1055–9.
Wang HW, Kuo CJ, Lin WR, Hsu CM, Ho YP, Lin CJ, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2016;29(4):392–9.
Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998;158(9):957–69.
Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med. 1993;119(9):924–35.
Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep. 2008;10(4):409–16.
Bonatti H, Sifri CD, Larcher C, Schneeberger S, Kotton C, Geltner C. Use of cidofovir for cytomegalovirus disease refractory to ganciclovir in solid organ recipients. Surg Infect. 2017;18(2):128–36.
El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016;128(23):2624–36.
Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45(2):228–33.
Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol. 2017;23(1):42–7.
Katz JA, Wagner ML, Gresik MV, Mahoney DH Jr, Fernbach DJ. Typhlitis. An 18-year experience and postmortem review. Cancer. 1990;65(4):1041–7.
Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013;56(5):711–7.
Neemann K, Freifeld A. Clostridium difficile-associated diarrhea in the oncology patient. J Oncol Pract. 2017;13(1):25–30.
McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;6(7):987–94.
Van Hise NW, Bryant AM, Hennessey EK, Crannage AJ, Khoury JA, Manian FA. Efficacy of oral vancomycin in preventing recurrent clostridium difficile infection in patients treated with systemic antimicrobial agents. Clin Infect Dis. 2016;63(5):651–3.
Chen CY, Cheng A, Huang SY, Sheng WH, Liu JH, Ko BS, et al. Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemia. PLoS One. 2013;8(4):e60624.
Feingold D, Steele SR, Lee S, Kaiser A, Boushey R, Buie WD, et al. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum. 2014;57(3):284–94.
Samdani T, Pieracci FM, Eachempati SR, Benarroch-Gampel J, Weiss A, Pietanza MC, et al. Colonic diverticulitis in chemotherapy patients: should operative indications change? A retrospective cohort study. Int J Surg. 2014;12(12):1489–94.
Rolston KV. Infections in cancer patients with solid tumors: a review. Infect Dis Ther. 2017;6(1):69–83.
Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, et al. Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(7):882–913.
Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol. 2006;4(9):1076–81.
Klaassen IL, de Haas V, van Wijk JA, Kaspers GJ, Bijlsma M, Bokenkamp A. Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer. 2011;56(5):868–70.
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–20.
Su H, Zhang Q, Li L, Zhao Y, Zhu J, Zhu M. Urinary tract infection (UTI) caused by fusarium proliferatum in an agranulocytosis patient and a review of published reports. Mycopathologia. 2016;181(1–2):131–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Velez, A.P., Greene, J.N., Lamarche, J. (2019). Gastrointestinal and Genitourinary Infections. In: Velez, A., Lamarche, J., Greene, J. (eds) Infections in Neutropenic Cancer Patients. Springer, Cham. https://doi.org/10.1007/978-3-030-21859-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-21859-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21858-4
Online ISBN: 978-3-030-21859-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)